Related references
Note: Only part of the references are listed.Robust and persistent reactivation of SIV and HIV by N-803 and depletion of CD8+ cells
Julia Bergild McBrien et al.
NATURE (2020)
Systemic HIV and SIV latency reversal via non-canonical NF-κB signalling in vivo
Christopher C. Nixon et al.
NATURE (2020)
Curing HIV: Seeking to Target and Clear Persistent Infection
David M. Margolis et al.
CELL (2020)
Delayed vaginal SHIV infection in VRC01 and anti-α4β7 treated rhesus macaques
Giulia Calenda et al.
PLOS PATHOGENS (2019)
Simian-Human Immunodeficiency Virus SHIV.CH505 Infection of Rhesus Macaques Results in Persistent Viral Replication and Induces Intestinal Immunopathology
Katharine J. Bar et al.
JOURNAL OF VIROLOGY (2019)
Analytical Treatment Interruption after Short-Term Antiretroviral Therapy in a Postnatally Simian-Human Immunodeficiency Virus-Infected Infant Rhesus Macaque Model
Ria Goswami et al.
MBIO (2019)
Getting the Kill into Shock and Kill: Strategies to Eliminate Latent HIV
Youry Kim et al.
CELL HOST & MICROBE (2018)
Mamu-B*17+ Rhesus Macaques Vaccinated with env, vif, and nef Manifest Early Control of SIVmac239 Replication
Mauricio A. Martins et al.
JOURNAL OF VIROLOGY (2018)
Short-Term Pegylated Interferon α2a Treatment Does Not Significantly Reduce the Viral Reservoir of Simian Immunodeficiency Virus-Infected, Antiretroviral Therapy-Treated Rhesus Macaques
David Palesch et al.
JOURNAL OF VIROLOGY (2018)
A Broadly Neutralizing Antibody Targets the Dynamic HIV Envelope Trimer Apex via a Long, Rigidified, and Anionic β-Hairpin Structure
Jeong Hyun Lee et al.
IMMUNITY (2017)
Interval dosing with the HDAC inhibitor vorinostat effectively reverses HIV latency
Nancie M. Archin et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
The making of bispecific antibodies
Ulrich Brinkmann et al.
MABS (2017)
Immune clearance of highly pathogenic SIV infection (vol 502, pg 100, 2013)
Scott G. Hansen et al.
NATURE (2017)
Hypersensitivity Reactions to Obinutuzumab in Cynomolgus Monkeys and Relevance to Humans
Elisabeth Husar et al.
TOXICOLOGIC PATHOLOGY (2017)
Translation and Clinical Development of Bispecific T-cell Engaging Antibodies for Cancer Treatment
T. Yuraszeck et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
Clinical Pharmacology and Translational Aspects of Bispecific Antibodies
A. Trivedi et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2017)
Short Communication: Comparative Evaluation of Coformulated Injectable Combination Antiretroviral Therapy Regimens in Simian Immunodeficiency Virus-Infected Rhesus Macaques
Gregory Q. Del Prete et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2016)
Towards HIV-1 remission: potential roles for broadly neutralizing antibodies
Ariel Halper-Stromberg et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Early short-term treatment with neutralizing human monoclonal antibodies halts SHIV infection in infant macaques
Ann J. Hessell et al.
NATURE MEDICINE (2016)
Envelope residue 375 substitutions in simian-human immunodeficiency viruses enhance CD4 binding and replication in rhesus macaques
Hui Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Elimination of HIV-1-infected cells by broadly neutralizing antibodies
Timothee Bruel et al.
NATURE COMMUNICATIONS (2016)
Identification of Common Features in Prototype Broadly Neutralizing Antibodies to HIV Envelope V2 Apex to Facilitate Vaccine Design
Raiees Andrabi et al.
IMMUNITY (2015)
Dual-Affinity Re-Targeting proteins direct T cell-mediated cytolysis of latently HIV-infected cells
Julia A. M. Sung et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117
Marina Caskey et al.
NATURE (2015)
Targeting HIV Reservoir in Infected CD4 T Cells by Dual-Affinity Re-targeting Molecules (DARTs) that Bind HIV Envelope and Recruit Cytotoxic T Cells
Derek D. Sloan et al.
PLOS PATHOGENS (2015)
Broadly Neutralizing Antibodies and Viral Inducers Decrease Rebound from HIV-1 Latent Reservoirs in Humanized Mice
Ariel Halper-Stromberg et al.
CELL (2014)
Establishment and maintenance of a PBMC repository for functional cellular studies in support of clinical vaccine trials
Anna Sambor et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2014)
Leukopak PBMC sample processing for preparing quality control material to support proficiency testing programs
Ambrosia Garcia et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2014)
HIV-1 Vaccine-Induced C1 and V2 Env-Specific Antibodies Synergize for Increased Antiviral Activities
Justin Pollara et al.
JOURNAL OF VIROLOGY (2014)
Formation, Clearance, Deposition, Pathogenicity, and Identification of Biopharmaceutical-related Immune Complexes: Review and Case Studies
Jennifer L. Rojko et al.
TOXICOLOGIC PATHOLOGY (2014)
Activation of HIV Transcription with Short-Course Vorinostat in HIV-Infected Patients on Suppressive Antiretroviral Therapy
Julian H. Elliott et al.
PLOS PATHOGENS (2014)
Histone Deacetylase Inhibitors Impair the Elimination of HIV-Infected Cells by Cytotoxic T-Lymphocytes
Richard Brad Jones et al.
PLOS PATHOGENS (2014)
Neutralizing Polyclonal IgG Present during Acute Infection Prevents Rapid Disease Onset in Simian-Human Immunodeficiency Virus SHIVSF162P3-Infected Infant Rhesus Macaques
J. Pablo Jaworski et al.
JOURNAL OF VIROLOGY (2013)
Comparative Analysis of Measures of Viral Reservoirs in HIV-1 Eradication Studies
Susanne Eriksson et al.
PLOS PATHOGENS (2013)
Stimulation of HIV-1-Specific Cytolytic T Lymphocytes Facilitates Elimination of Latent Viral Reservoir after Virus Reactivation
Liang Shan et al.
IMMUNITY (2012)
Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
N. M. Archin et al.
NATURE (2012)
Broad neutralization coverage of HIV by multiple highly potent antibodies
Laura M. Walker et al.
NATURE (2011)
Replication competent molecular clones of HIV-1 expressing Renilla luciferase facilitate the analysis of antibody inhibition in PBMC
Tara G. Edmonds et al.
VIROLOGY (2010)
Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques
Ann J. Hessell et al.
NATURE MEDICINE (2009)
Mamu-B*08-positive macaques control simian immunodeficiency virus replication
John T. Loffredo et al.
JOURNAL OF VIROLOGY (2007)
The high-frequency major histocompatibility complex class I allele Mamu-B*17 is associated with control of simian immunodeficiency virus SIVmac239 replication
Levi J. Yant et al.
JOURNAL OF VIROLOGY (2006)
Share Paper
